STOCK TITAN

Lifeward Ltd. (LFWD) VP granted 50,000 RSUs under 2025 plan

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Lifeward Ltd. reported an insider equity award to one of its officers. The company granted 50,000 ordinary shares, par value NIS 1.75 per share, in the form of restricted stock units (RSUs) on December 11, 2025 under its 2025 Incentive Compensation Plan.

The RSUs vest ratably in four equal annual installments starting on the grant date, meaning the officer receives one quarter of the shares each year as they vest. The transaction is coded as an acquisition at a stated price of $0, reflecting an equity compensation award rather than a market purchase.

Following this grant, the reporting person beneficially owns 96,067 ordinary shares, held directly. The filing is made by a single reporting person, who serves as VP of Market Access & Strategy at Lifeward Ltd.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lynch Jeannine

(Last) (First) (Middle)
C/O LIFEWARD LTD.
200 DONALD LYNCH BLVD.

(Street)
MARLBOROUGH MA 01752

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lifeward Ltd. [ LFWD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP of Market Access & Strategy
3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares, par value NIS 1.75 per share 12/11/2025 A 50,000(1) A $0 96,067 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents 50,000 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on December 11, 2025 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal annual installments commencing as of the Grant Date.
/s/ Jeannine Lynch 12/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Lifeward Ltd. (LFWD) report in this Form 4?

Lifeward Ltd. reported that an officer acquired 50,000 ordinary shares in the form of restricted stock units (RSUs) granted on December 11, 2025 under the company’s 2025 Incentive Compensation Plan.

Who is the reporting person and what is their role at Lifeward Ltd. (LFWD)?

The reporting person is Jeannine Lynch, who serves as VP of Market Access & Strategy at Lifeward Ltd., as indicated in the filing.

How many RSUs were granted and how do they vest for the Lifeward Ltd. (LFWD) officer?

The officer was granted 50,000 RSUs. These RSUs vest ratably in four equal annual installments, commencing as of the December 11, 2025 grant date, so one quarter of the units vest each year.

What is the total number of Lifeward Ltd. (LFWD) shares the officer owns after this transaction?

After the reported RSU grant, the officer beneficially owns 96,067 ordinary shares of Lifeward Ltd., held in direct ownership.

What price was paid for the RSUs reported by Lifeward Ltd. (LFWD)?

The transaction table lists the price for the RSU acquisition as $0, consistent with an equity compensation grant rather than a cash purchase.

What type of security was granted in the Lifeward Ltd. (LFWD) Form 4 transaction?

The grant consists of ordinary shares of Lifeward Ltd., each with a par value of NIS 1.75, issuable upon vesting of the 50,000 restricted stock units (RSUs).

Is the Lifeward Ltd. (LFWD) insider ownership reported as direct or indirect?

The filing shows that the 96,067 ordinary shares beneficially owned following the transaction are held in direct (D) ownership by the reporting person.

Lifeward Ltd

NASDAQ:LFWD

LFWD Rankings

LFWD Latest News

LFWD Latest SEC Filings

LFWD Stock Data

12.45M
17.90M
2.07%
2.89%
7.44%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
Israel
MARLBOROUGH